Health Care & Life Sciences » Biotechnology | Puma Biotechnology Inc.

Puma Biotechnology Inc.

Puma Biotechnology Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
38.02 M
Public Float
28.39 M
Puma Biotechnology Inc.
Stock Exchange New York Stock Exchange
EPS
$2.61
Market Cap
$471.84 M
Shares Outstanding
38.61 M
Public Float
32.6 M

Profile

Address
10880 Wilshire Boulevard
Los Angeles California 90024
United States
Employees -
Website http://www.pumabiotechnology.com
Updated 07/08/2019
Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use.

Financials

View All

Alan H. Auerbach
Chairman, President, CEO & Secretary
Michael Patrick Miller
Independent Director